Results 51 to 60 of about 9,079 (152)

Combination of Systemic and Lock-Therapies with Micafungin Eradicate Catheter-Based Biofilms and Infections Caused by Candida albicans and Candida parapsilosis in Neutropenic Rabbit Models

open access: yesJournal of Fungi
Vascular catheter-related infections, primarily caused by Candida albicans and Candida parapsilosis, pose significant challenges due to the formation of biofilms on catheters, leading to refractory disease and considerable morbidity.
Ruta Petraitiene   +6 more
doaj   +1 more source

Cost Analysis of the Use of Voriconazole, Posaconazole and Micafungin in the Primary Prophylaxis of Invasive Fungal Infections in Recipients of Allogeneic Hematopoietic Stem Cell Transplants

open access: yesJournal of Health Economics and Outcomes Research, 2015
# Objectives Compare the cost of the primary prophylaxis of invasive fungal infections (IFI) with voriconazole, posaconazole, and micafungin in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) in hospitals of the National ...
Santiago Grau   +8 more
doaj   +1 more source

Coagulation dysfunction events associated with echinocandins: a real-world study from FDA adverse event reporting system (FAERS) database

open access: yesThrombosis Journal
Background Echinocandins belong to the fourth generation of antifungals, and there are no systematic studies on their risk in coagulation dysfunction; this study will predict the risk of coagulation dysfunction of echinocandins using the US Food and Drug
Qian Cheng   +7 more
doaj   +1 more source

Case Report: Micafungin for treating Candida glabrata urinary infection: a clinical case in a premature neonate

open access: yesFrontiers in Pediatrics
Urinary tract infections (UTIs) associated with indwelling urinary catheterization (IUC) in premature newborns (PNBs) pose a significant challenge in neonatal intensive care units (NICUs) due to the vulnerability of this population to infections and the ...
Carlos Javier Parramon-Teixido   +6 more
doaj   +1 more source

Invasive Candidiasis in Infants and Children: Recent Advances in Epidemiology, Diagnosis, and Treatment

open access: yesJournal of Fungi, 2019
This paper reviews recent advances in three selected areas of pediatric invasive candidiasis: epidemiology, diagnosis, and treatment. Although the epidemiological trends of pediatric invasive candidiasis illustrate a declining incidence, this infection ...
Thomas J. Walsh   +4 more
doaj   +1 more source

The activity of micafungin against clinical isolates of non-albicans Candida spp.

open access: yesCurrent Issues in Pharmacy and Medical Sciences, 2015
Infections caused by non-albicans Candida spp. are an important medical problem in people from risk groups, e.g. hematooncological patients. The aim of this paper was to analyse the in vitro activity of micafungin against 30 clinical isolates of non ...
Biernasiuk Anna   +3 more
doaj   +1 more source

Micafungin in the treatment of invasive candidiasis and invasive aspergillosis

open access: yesInfection and Drug Resistance, 2009
Nathan P Wiederhold1, Jason M Cota2, Christopher R Frei11University of Texas at Austin College of Pharmacy, Austin, Texas, USA; 2University of the Incarnate Word Feik School of Pharmacy, San Antonio, Texas, USAAbstract: Micafungin is an echinocandin ...
Nathan P Wiederhold   +2 more
doaj  

Paediatric Acute Generalised and Localised Exanthematous Pustulosis: A Systematic Review

open access: yes
JEADV Clinical Practice, Volume 5, Issue 2, Page 678-681, June 2026.
Miranda K. Branyiczky   +6 more
wiley   +1 more source

Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis - review of the literature

open access: yesEuropean Journal of Medical Research, 2011
Echinocandins represent the newest class of antifungal agents. Currently, three echinocandins, anidulafungin, caspofungin and micafungin are licensed for clinical use in various indications.
Kofla G, Ruhnke M
doaj   +1 more source

INVASIVE FUNGAL INFECTIONS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (TCTH) RECIPIENTS UNDER ANTIFUNGAL PROPHYLAXIS WITH ECHINOCANDIN: BRAZILIAN EXPERIENCE

open access: yesBrazilian Journal of Infectious Diseases
Introduction: Onco-hematologic patients undergoing TCTH are at high risk for invasive fungal infections (IFI), one of the main causes of morbidity and mortality in this population.
Jessica Fernandes Ramos   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy